Stanhope Medical Limited 08869824 false 2025-04-01 2026-03-31 2026-03-31 The principal activity of the company is that of the provision of medical insurance and consulting services. Digita Accounts Production Advanced 6.30.9574.0 true 08869824 2025-04-01 2026-03-31 08869824 2026-03-31 08869824 core:CurrentFinancialInstruments core:WithinOneYear 2026-03-31 08869824 bus:Micro-entities 2025-04-01 2026-03-31 08869824 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 08869824 bus:FilletedAccounts 2025-04-01 2026-03-31 08869824 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 08869824 bus:RegisteredOffice 2025-04-01 2026-03-31 08869824 bus:Director1 2025-04-01 2026-03-31 08869824 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 08869824 countries:EnglandWales 2025-04-01 2026-03-31 08869824 2024-04-01 2025-03-31 08869824 2025-03-31 08869824 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 iso4217:GBP xbrli:pure

Registration number: 08869824

Stanhope Medical Limited
Unaudited Financial Statements
for the Year Ended 31 March 2026

Stanhope Medical Limited

Statement of Financial Position as at 31 March 2026

| 2026 £ | 2025 £
Fixed assets | 551 | 690
Current assets | 19,829 | 13,116
Creditors: Amounts falling due within one year | (13,304) | (11,208)
Net current assets | 6,525 | 1,908
Total assets less current liabilities | 7,076 | 2,598
Accruals and deferred income | (2,400) | (2,400)
| 4,676 | 198
Capital and reserves | 4,676 | 198

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
1 Suffolk Way
Sevenoaks
Kent
TN13 1YL

2 | Basis of Preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

3 | Staff numbers

The average number of persons employed by the company (including the director) during the year was 2 (2025 - 2).

4 | Transactions with Directors

At 31 March 2026 an amount of £103 (2025: £2,213) was due from the director. During the year, there were advances of £3,936 and repayments of £6,046. No interest has been charged. There are no set terms in place.

Stanhope Medical Limited

Statement of Financial Position as at 31 March 2026

For the financial year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Income Statement.

Approved and authorised by the director on 26 June 2026

......................................... Mr G Walters Director

Company registration number: 08869824